These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3414725)

  • 1. The presence of cachectin/tumor necrosis factor in human disease states.
    Beutler B
    Am J Med; 1988 Sep; 85(3):287-8. PubMed ID: 3414725
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.
    Lähdevirta J; Maury CP; Teppo AM; Repo H
    Am J Med; 1988 Sep; 85(3):289-91. PubMed ID: 3414726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cachectin/tumor necrosis factor in AIDS.
    Tracey KJ; Cerami A
    Cancer Cells; 1989 Oct; 1(2):62-3. PubMed ID: 2641271
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokines and acquired immunodeficiency syndrome.
    Fuchs D; Reibnegger G; Dierich MP; Wachter H
    Am J Med; 1989 Apr; 86(4):509. PubMed ID: 2494885
    [No Abstract]   [Full Text] [Related]  

  • 5. Cachectin: a hormone that triggers acute shock and chronic cachexia.
    Tracey KJ; Lowry SF; Cerami A
    J Infect Dis; 1988 Mar; 157(3):413-20. PubMed ID: 3278061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TNF-alpha in the development of acquired immunodeficiency syndrome].
    Espinós Pérez D
    An R Acad Nac Med (Madr); 1994; 111(1):219-31. PubMed ID: 7978121
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum level of TNF alpha in HIV-infected individuals.
    Kobayashi S; Hamamoto Y; Kobayashi N; Yamamoto N
    AIDS; 1990 Feb; 4(2):169-70. PubMed ID: 2328100
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of in vivo detection of tumor necrosis factor.
    Remick DG
    Lab Invest; 1991 Sep; 65(3):259-61. PubMed ID: 1890805
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumour necrosis factor.
    Michihiko S; Yamamoto N; Shinozaki F; Shimada K; Soma G; Kobayashi N
    Lancet; 1989 May; 1(8648):1206-7. PubMed ID: 2566769
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased short-term production of tumor necrosis factor-alpha and interleukin-1beta in human immunodeficiency virus-seropositive subjects.
    Ullum H; Victor J; Katzenstein TL; Gerstoft J; Gøtzsche PC; Bendtzen K; Skinhøj P; Pedersen BK
    J Infect Dis; 1997 Jun; 175(6):1507-10. PubMed ID: 9180195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide.
    Munis JR; Richman DD; Kornbluth RS
    J Clin Invest; 1990 Feb; 85(2):591-6. PubMed ID: 2298923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement.
    Grimaldi LM; Martino GV; Franciotta DM; Brustia R; Castagna A; Pristerà R; Lazzarin A
    Ann Neurol; 1991 Jan; 29(1):21-5. PubMed ID: 1996875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex regulation and biology of TNF (cachectin).
    Beutler B
    Crit Rev Oncog; 1990; 2(1):9-18. PubMed ID: 2091751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of tumor necrosis factor receptor expression by acid-labile interferon-alpha from AIDS sera.
    Lau AS; Der SD; Read SE; Williams BR
    AIDS Res Hum Retroviruses; 1991 Jun; 7(6):545-52. PubMed ID: 1657073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.
    Maury CP; Teppo AM
    J Exp Med; 1987 Oct; 166(4):1132-7. PubMed ID: 3309124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat.
    Stovroff MC; Fraker DL; Swedenborg JA; Norton JA
    Cancer Res; 1988 Aug; 48(16):4567-72. PubMed ID: 3165053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo.
    Moldawer LL; Marano MA; Wei H; Fong Y; Silen ML; Kuo G; Manogue KR; Vlassara H; Cohen H; Cerami A
    FASEB J; 1989 Mar; 3(5):1637-43. PubMed ID: 2784116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-α in HIV-infected patients treated with ritonavir-boosted protease inhibitors.
    Calza L; Trapani F; Bartoletti M; Manfredi R; Colangeli V; Borderi M; Grossi G; Motta R; Viale P
    HIV Clin Trials; 2012; 13(3):153-61. PubMed ID: 22592095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cachectin/tumour necrosis factor-alpha in the circulation of patients with rheumatic disease.
    Maury CP; Teppo AM
    Int J Tissue React; 1989; 11(4):189-93. PubMed ID: 2634628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.